ORLNC1 Suppresses Cell Growth in HER2-Positive Breast Cancer via miRNA-296 Sponging
Authors:
- 1 May 2023
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 23 (4) , 289-299
Abstract
Background: Accumulating research has demonstrated that aberrant levels of long noncoding RNAs (LncRNAs) are related to cancer progression. The effects of ORLNC1 in HER2+ breast cancer have yet to be explored. Methods: Real-time PCR was used to examine the expression of LncRNA ORLNC1 in HER+ breast cancer. CCK-8, wound healing and cell invasion assays were used to examine the effect of LncRNA ORLNC1 on HER+ breast cancer cells. Luciferase reporter assay was utilized to determine the regulatory relationship between LncRNA ORLNC1 and miR-296. Western blotting was used to measure the expression of PTEN. Xenograft mouse model was used to examine the effect of LncRNA ORLNC1 on tumor progression in vivo. Results: In this study, our findings revealed downregulation of ORLNC1 in HER2+ breast cancer specimens and cell lines. Low levels of ORLNC1 were related to poor prognosis and advanced cancer stage. Using gain- and loss-of-function assays, the ability of these tumor cells to proliferate was found to be inhibited by ORLNC1 in vitro and in vivo. Further analyses revealed that miR-296/PTEN axis is directly targeted by ORLNC1. Consequently, over-expression of miR-296 efficiently abrogated the upregulation of PTEN induced by ORLNC1, suggesting that ORLNC1 positively regulates PTEN expression by competitively binding to miR-296. Conclusion: Our results indicate that lncRNA ORLNC1 acts as a tumor suppressor by regulating the miR-296/PTEN axis in HER2+ breast cancer.Keywords
Funding Information
- Scientific Research Project of the Beihai Science and Technology Bureau (202082044)
This publication has 45 references indexed in Scilit:
- The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells — A data descriptionGenomics Data, 2014
- The tumor suppressor PTEN interacts with p53 in hereditary cancerInternational Journal of Oncology, 2014
- The Functions of MicroRNAs and Long Non-Coding RNAs in Embryonic and Induced Pluripotent Stem CellsGenomics, Proteomics & Bioinformatics, 2013
- Survival of HER2-Positive Breast Cancer Cells: Receptor Signaling to Apoptotic Control CentersGenes & Cancer, 2013
- Long Noncoding RNAs: Past, Present, and FutureGenetics, 2013
- The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cellsMolecular Oncology, 2012
- DYNLT3 Is Required for Chromosome Alignment During Mouse Oocyte Meiotic MaturationReproductive Sciences, 2011
- MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancerCell Cycle, 2011
- PTEN Tumor Suppressor Network in PI3K-Akt Pathway ControlGenes & Cancer, 2010
- Her2-positive breast cancer: Herceptin and beyondEuropean Journal of Cancer, 2008